ClinicalTrials.Veeva

Menu

Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a Comparison Study (LBBAP)

U

Universitair Ziekenhuis Brussel

Status

Enrolling

Conditions

Biventricular Cardiac Pacemaker Malfunction
Bradyarrhythmia
Pacemaker Syndrome

Treatments

Device: Left Bundel Area Pacing

Study type

Interventional

Funder types

Other

Identifiers

NCT05401851
EC-2022-020

Details and patient eligibility

About

Study of the ventricular activation patterns during left bundle area pacing and compare it with baseline activation during normal sinus rhythm in patients with and without baseline bundle branch conduction disorder.

Full description

Right ventricular (RV) pacing has long been the gold standard treatment for symptomatic brady arrhythmias. Right ventricular apical pacing has shown to cause electrical and mechanical desynchrony resulting in left ventricular (LV) dysfunction, and, in some cases, clinical heart failure together with other mechanical and arrhythmic complications. Hence, it was necessary to find a more physiologic method of pacing that ensures synchrony. His bundle pacing was first described in 2000, and is more recently adapted as a pacing method with less deleterious effects on the RV. However, lead dislodgement, high pacing thresholds, battery depletion, and difficulty identifying the exact location of His bundle were the most significant concerns related to this method. Subsequently, left bundle branch area pacing (LBB-AP), first described in 2017 by Huang et al, has emerged as safe alternative with excellent lead stability and capture threshold, and more ability to correct distal conduction disease as compared to His bundle pacing. Recent studies report promising mid-term outcome concerning left ventricular desynchrony. To the best of our knowledge, bi-ventricular activation was never studied in patients with LBB-AP.

Multiple tools have been used to assess biventricular (BiV) synchrony specially with chronic resynchronization therapy (CRT) including echocardiography and 12 lead ECG. Eschalier et al. found that epicardial noninvasive ECG mapping, was better at predicting clinical CRT response than QRS duration or the presence of LBBB. Activation patterns and timings with RV apical pacing, native LBBB, and BiV pacing have been well studied using this tool. With LBBP, however, these activation parameters have not yet been described.

This study aims to evaluate bi-ventricular activation in patients equipped with LBB-AP using non-invasive 3D mapping system in patients with or without baseline ventricular conduction disorder.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 30 patients with a functional LBB-AP pacemaker

Exclusion criteria

  • Age < 18 years
  • Previous cardiac surgery
  • Cardiomyopathy with documented ventricular scar
  • Patients with prior pacemaker

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Body surface mapping
Other group
Description:
With the Insite Vest, activation of the epicardium will be performed.
Treatment:
Device: Left Bundel Area Pacing

Trial contacts and locations

1

Loading...

Central trial contact

Carlo de Asmundis, MD, PhD; Aurélie Dubois

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems